C4 Therapeutics (CCCC) Q4 2022 Earnings

23FebConfirmed
May 22
Aug 22
Nov 22
Q4 2022
-0.76
-0.69
-0.63
-0.56

Details

Expected EPS
-0.74
Actual EPS
-0.76
Surprise EPS
-0.02
Surprise Percent
+2.7%

Description

C4 Therapeutics (CCCC) has reported earnings of -0.76 per share for Q4 2022.

0 Comments

Share your thoughts